Pharmacokinetics and Pharmacodynamics of Cilofexor in Adults With Normal and Impaired Hepatic Function

Clinical trial NCT02808312 · COMPLETED

Trial details

NCT number: NCT02808312
Sponsor: Gilead Sciences
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Nonalcoholic Steatohepatitis (NASH)Primary Sclerosing Cholangitis (PSC)

Start date: 2016-07-13
Primary completion: 2018-10-16
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.